<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NCP</journal-id>
<journal-id journal-id-type="hwp">spncp</journal-id>
<journal-id journal-id-type="nlm-ta">Nutr Clin Pract</journal-id>
<journal-title>Nutrition in Clinical Practice</journal-title>
<issn pub-type="ppub">0884-5336</issn>
<issn pub-type="epub">1941-2452</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0884533613487219</article-id>
<article-id pub-id-type="publisher-id">10.1177_0884533613487219</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Soluble Receptor of Transferrin (sTfR) as a Marker of Iron Deficiency in Inflammatory Conditions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Hurtado-Torres</surname><given-names>Gilberto Fabian</given-names></name>
<degrees>MD, MEd</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Castanedo-Cazares</surname><given-names>Juan Pablo</given-names></name>
<degrees>MD, MSc</degrees>
</contrib>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>4</issue>
<fpage>522</fpage>
<lpage>522</lpage>
<permissions>
<copyright-statement>© 2013 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Liu et al<sup><xref ref-type="bibr" rid="bibr1-0884533613487219">1</xref></sup> report that the combination of enteral nutrition (EN) plus erythropoietin (EPO) is superior to EN alone for the correction of anemia in patients with Crohn’s disease and ferropenic anemia. They assumed that anemia was a consequence of iron deficiency and chronic inflammation, establishing the need for iron supplementation.</p>
<p>All the patients in the study had positive inflammatory serum markers such as C-reactive protein and erythrocyte sedimentation rate, and iron deficiency was established exclusively by biochemical parameters (ie, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, mean corpuscular volume, red cell distribution). It is worth noting that under this inflammatory scenario, these indicators of iron deficiency would not be reliable without knowing serum ferritin levels or other iron status indices.<sup><xref ref-type="bibr" rid="bibr2-0884533613487219">2</xref>,<xref ref-type="bibr" rid="bibr3-0884533613487219">3</xref></sup></p>
<p>After the intervention, despite the fact that hemoglobin values were corrected in both interventions, biological indicators of iron deficiency did not change. It was hypothesized that the combination of EPO and iron delivered by the enteral formula contributed to the restitution of erythropoiesis and improved the anemia, with an interesting decline in the inflammatory markers for this arm.</p>
<p>In patients with inflammatory and chronic conditions, it is difficult to distinguish anemia due to iron deficiency from anemia due to chronic illness.<sup><xref ref-type="bibr" rid="bibr2-0884533613487219">2</xref>,<xref ref-type="bibr" rid="bibr4-0884533613487219">4</xref>,<xref ref-type="bibr" rid="bibr5-0884533613487219">5</xref></sup> The distribution and kinetics of traditional iron deficiency markers are modified by the undergoing inflammatory condition, and as consequence, their ability to reflect true iron status is significantly reduced.<sup><xref ref-type="bibr" rid="bibr2-0884533613487219">2</xref>,<xref ref-type="bibr" rid="bibr4-0884533613487219">4</xref>,<xref ref-type="bibr" rid="bibr5-0884533613487219">5</xref></sup></p>
<p>To cope with this limitation, the soluble receptor of transferrin (sTfR), a truncated portion of the cellular transferrin receptor and one of the main regulators of iron homeostasis, is a relatively novel proposed marker.<sup><xref ref-type="bibr" rid="bibr4-0884533613487219">4</xref><xref ref-type="bibr" rid="bibr5-0884533613487219"/>-<xref ref-type="bibr" rid="bibr6-0884533613487219">6</xref></sup> The sTfR increases in iron deficiency settings, and its values are not significantly affected by the inflammatory response. Besides its role as an indicator of iron deficiency, it also informs about the iron replenishment stores since it decreases after iron restitution.<sup><xref ref-type="bibr" rid="bibr4-0884533613487219">4</xref><xref ref-type="bibr" rid="bibr5-0884533613487219"/>-<xref ref-type="bibr" rid="bibr6-0884533613487219">6</xref></sup> These features make sTfR a suitable marker that could have been used as a true indicator of the mechanism proposed by the authors.</p>
<p>Finally, we also think that the associated immunomodulatory effects of erythropoietin cannot be excluded as a potential explanation for the decreased C-reactive protein levels observed in the EN and EPO arm.<sup><xref ref-type="bibr" rid="bibr7-0884533613487219">7</xref></sup></p>
<sig-block>
<sig>Gilberto Fabian Hurtado-Torres, MD, MEd<break/>Juan Pablo Castanedo-Cazares, MD, MSc<break/><italic>University of San Luis Potosi, SLP, Mexico</italic></sig>
</sig-block>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0884533613487219">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>S</given-names></name>
<name><surname>Ren</surname><given-names>J</given-names></name>
<name><surname>Hong</surname><given-names>Z</given-names></name><etal/>
</person-group>. <article-title>Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn’s disease: a prospective cohort study</article-title>. <source>Nutr Clin Pract</source>. <year>2013</year>;<volume>28</volume>(<issue>1</issue>):<fpage>120</fpage>-<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr2-0884533613487219">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clark</surname><given-names>SF</given-names></name>
</person-group>. <article-title>Iron deficiency anemia</article-title>. <source>Nutr Clin Pract</source>. <year>2008</year>;<volume>23</volume>(<issue>2</issue>):<fpage>128</fpage>-<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr3-0884533613487219">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gabay</surname><given-names>C</given-names></name>
<name><surname>Kushner</surname><given-names>I</given-names></name>
</person-group>. <article-title>Acute-phase proteins and other systemic responses to inflammation</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>:<fpage>448</fpage>-<lpage>454</lpage>.</citation>
</ref>
<ref id="bibr4-0884533613487219">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Speeckaert</surname><given-names>MM</given-names></name>
<name><surname>Speeckaert</surname><given-names>R</given-names></name>
<name><surname>Delanghe</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Biological and clinical aspects of soluble transferrin receptor</article-title>. <source>Crit Rev Clin Lab Sci</source>. <year>2010</year>;<volume>47</volume>(<issue>5-6</issue>):<fpage>213</fpage>-<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr5-0884533613487219">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beguin</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Soluble transferrin receptor for the evaluation of erythropoiesis and iron status</article-title>. <source>Clin Chim Acta</source>. <year>2003</year>;<volume>329</volume>(<issue>1-2</issue>):<fpage>9</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr6-0884533613487219">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marković</surname><given-names>M</given-names></name>
<name><surname>Majkić-Singh</surname><given-names>N</given-names></name>
<name><surname>Subota</surname><given-names>V</given-names></name>
</person-group>. <article-title>Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease</article-title>. <source>Scand J Clin Lab Invest</source>. <year>2005</year>;<volume>65</volume>(<issue>7</issue>):<fpage>571</fpage>-<lpage>576</lpage>.</citation>
</ref>
<ref id="bibr7-0884533613487219">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meng</surname><given-names>R</given-names></name>
<name><surname>Zhu</surname><given-names>D</given-names></name>
<name><surname>Bi</surname><given-names>Y</given-names></name>
<name><surname>Yang</surname><given-names>D</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>1</issue>):<fpage>e53557</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>